Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact Pricing
Login Book a demo
Owl Therapeutics logo — Unlocking Wisdom for Brain Health

Owl Therapeutics

Unlocking Wisdom for Brain Health

Founded 2023 United States San Antonio, United States 2 employees Biopharma

General Information

Company Name Owl Therapeutics
Founded Year 2023
Location United States San Antonio, United States +1
Founders / Decision Makers
Team member
Employees 2
Industries Biopharma
Social

Get notified when Owl Therapeutics moves

Funding, new markets, leadership changes, hiring surges — one e-mail, only when something happens.

Free · no account needed

About Owl Therapeutics

Owl Therapeutics is a wholly-owned subsidiary of Gryphon Bio​ that is dedicated to unlocking wisdom for brain health. Specializing in the development of diagnostic-powered therapeutics for traumatic brain injury (TBI) and brain health, Owl Therapeutics has rapidly constructed a diversified pipeline of small and large molecule medicines to address the unmet needs of patients suffering from neurodegenerative diseases. Established in 2023, the company operates in the Biopharma sector and is headquartered in the United States. It is helmed by a proven, cohesive, interdisciplinary, and internationally recognized team with extensive scientific, clinical, and business experience in drug development and commercialization. Currently, there is no publicly disclosed information about the latest investment or specific investors.

Taxonomy: Owl Therapeutics, Gryphon Bio, biopharmaceutical company, clinical-stage, therapeutics, traumatic brain injury, neurodegenerative disease, drug development, diagnostics, brain health

No funding data available for Owl Therapeutics yet.

Get notified when Owl Therapeutics raises funding

Owl Therapeutics Alternatives & Competitors

Owl Therapeutics vs
BBB Therapeutics
BBB Therapeutics The Netherlands

Combines existing drugs with it's proprietary for enhanced drug delivery across the blood-brain barr...

Unknown
21 employees
Biopharma, Biotechnology
Owl Therapeutics vs
Reglagene
Reglagene United States

The Brain: The Next Frontier

Series Unknown
13 employees
Biotechnology, Life Sciences
Owl Therapeutics vs
Sinaptica Therapeutics
Sinaptica Therapeutics United States

Personalized, precision neuromodulation for Alzheimer‘s disease….and beyond.

Pre Seed
13 employees
Health and Wellness, Manufacturing

FAQ About Owl Therapeutics

Unlocking Wisdom for Brain Health
Owl Therapeutics was founded in 2023.
Owl Therapeutics is headquartered in San Antonio, United States.
Owl Therapeutics operates in the following industries: Biopharma.
Owl Therapeutics has approximately 2 employees.
Top alternatives and competitors to Owl Therapeutics include BBB Therapeutics, Reglagene, Sinaptica Therapeutics, Reservoir Neuroscience, Gryphon Bio. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Owl Therapeutics and BBB Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Don't just browse. Track.

Signal Tracker monitors Owl Therapeutics and millions of companies for funding rounds, hiring surges, product changes, and 40+ signal types — so you never miss an opportunity.

See how it works

One analytics cookie (Google Analytics). Cookie Policy